Silverback Therapeutics, Inc.
(NASDAQ : SBTX)

... ...
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson 1.13%163.560.7%$1160.35m
PFEPfizer Inc. 0.19%36.550.9%$1138.06m
LLYEli Lilly & Co. 1.95%206.301.1%$934.48m
ABBVAbbVie, Inc. -0.34%110.881.9%$732.28m
BMYBristol-Myers Squibb Co. 0.61%64.571.0%$679.31m
MRKMerck & Co., Inc. -0.26%80.970.7%$677.96m
AZNAstraZeneca Plc 1.33%53.251.2%$669.74m
ARCTArcturus Therapeutics Holdings, Inc. 6.16%67.700.0%$229.98m
GRTSGritstone Oncology, Inc. 6.11%27.110.0%$211.05m
VTRSViatris, Inc. 0.69%17.430.0%$193.56m
RPRXRoyalty Pharma Plc 1.47%51.160.2%$174.27m
NVSNovartis AG 0.06%96.940.2%$174.04m
GSKGlaxoSmithKline Plc 1.54%38.360.2%$154.42m
SNYSanofi 0.10%49.690.2%$134.98m
RGENRepligen Corp. 1.11%219.326.9%$78.39m

Company Profile

Silverback Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on proprietary ImmunoTAC technology platform to develop systemically delivered, tissue targeted therapeutics for the treatment of cancer, chronic viral infections, and other serious diseases. The company was founded by Peter A. Thompson on January 4, 2016 and is headquartered in Seattle, WA.